Keith R. Gollust has been a Director at Madrigal Pharmaceuticals, Inc., since July 2016. Mr. Gollust served on the Board of Directors of Synta from July 2002 through the Merger in July 2016 and as Chairman of the Synta Board of Directors from September 2002 through the Merger in July 2016. Mr. Gollust is a Private Investor and President of Gollust Management, Inc.
Madrigal has a market cap of roughly $1.2B in 2019 and
Residential
Links: www.bloomberg.com
By: borlefborlef